Dimolegin
Small moleculeexperimental
Clinical trial activity
4 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
3
Phase 3
2
Phase 4
0
Earliest trial started Jan 25, 2017 (NCT05181241)
Timeline
Indications
Mechanism of action
- Coagulation factor XINHIBITOR
F10 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07124819 | Phase 3 | Jul 22, 2024 | Government of Russia |
| NCT05185804 | Phase 3 | Feb 8, 2021 | I.M. Sechenov First Moscow State Medical University, PharmaDiall Ltd. |
| NCT05189002 | Phase 2 | May 31, 2019 | I.M. Sechenov First Moscow State Medical University, PharmaDiall Ltd. |
| NCT05181241 | Phase 1 | Jan 25, 2017 | PharmaDiall Ltd. |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| PharmaDiall Ltd. | For profit | 3 | 3 | 3 | 2017 |
| I.M. Sechenov First Moscow State Medical University | Academic/Hospital | 2 | 0 | 2 | 2019 |
| Government of Russia | Government | 1 | 1 | 1 | 2024 |
3 organizations
Page 1 / 1